Somashekar Narasimhaiah
Bengaluru, KA, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial).
Journal: BMJ (Clinical research ed.)
Published: April 10, 2026
PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial.
Journal: BMJ open
Published: December 07, 2024
Prevalence and factors associated with tuberculosis infection in India.
Journal: Journal of infection and public health
Published: June 26, 2023
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: April 20, 2021
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
Journal: The Indian journal of medical research
Published: September 21, 2020
Chest Radiography and Xpert MTB/RIF® Testing in Persons with Presumptive Pulmonary TB: Gaps and Challenges from a District in Karnataka, India.
Journal: Tuberculosis research and treatment
Published: September 08, 2019
'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
Journal: The Indian journal of tuberculosis
Published: June 04, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026